(G73.0*) Myasthenic syndromes in endocrine diseases

More details coming soon

Icon
NaN% mortality rate associated with the disease myasthenic syndromes in endocrine diseases

Diagnosis myasthenic syndromes in endocrine diseases is diagnosed Prevalent in Women Only

0

Men receive the diagnosis myasthenic syndromes in endocrine diseases

0 (No mortality)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0

Women receive the diagnosis myasthenic syndromes in endocrine diseases

0 (No mortality)

Died from this diagnosis.

Risk Group for the Disease myasthenic syndromes in endocrine diseases - Men and Women aged 0

Icon
No Cases of the Disease Myasthenic syndromes in endocrine diseases identified in Men
Icon
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
Icon
No Cases of the Disease Myasthenic syndromes in endocrine diseases identified in Men

Disease Features myasthenic syndromes in endocrine diseases

Icon
Absence or low individual and public risk
Icon

Myasthenic syndromes in endocrine diseases - what does this mean

Myasthenic syndromes in endocrine diseases occur when there is an imbalance of hormones in the body due to a malfunctioning endocrine system. this can lead to an abnormal production of neurotransmitters, which can affect the transmission of signals from the nerves to the muscles, resulting in myasthenic syndromes.

What happens during the disease - myasthenic syndromes in endocrine diseases

Myasthenic syndromes in endocrine diseases are caused by an autoimmune response to the endocrine glands which leads to an attack on the neuromuscular junction. this results in an abnormal transmission of nerve impulses, causing muscle weakness and fatigue.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Blood tests
  • Electrophysiological tests
  • Imaging tests
  • Genetic testing
  • Thyroid function tests
  • Adrenal function tests
  • Parathyroid hormone tests
  • Growth hormone tests
  • Pituitary hormone tests
  • Neuropsychological tests

Treatment and Medical Assistance

Main goal of the treatment: To reduce the symptoms and improve the quality of life of patients with myasthenic syndromes in endocrine diseases.
  • Administering medications to reduce muscle weakness and fatigue
  • Providing supportive care and monitoring of the patient’s condition
  • Providing physical therapy to improve muscle strength and endurance
  • Providing dietary and nutritional counseling to improve overall health
  • Providing education about the disease and its treatment
  • Providing psychosocial support for patients and their families
  • Monitoring for any changes in the patient’s condition
  • Referring the patient to specialists for further evaluation and treatment
Icon
No Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Myasthenic syndromes in endocrine diseases - Prevention

Preventing myasthenic syndromes in endocrine diseases involves careful management of the underlying endocrine disorder, as well as regular monitoring of symptoms and signs of myasthenia gravis. additionally, it is important to avoid certain medications that may worsen the condition, such as beta-blockers and calcium channel blockers. finally, it is important to maintain good nutrition and exercise to maintain muscle strength and function.